期刊
EXPERT OPINION ON BIOLOGICAL THERAPY
卷 6, 期 3, 页码 301-310出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14712598.6.3.301
关键词
Fluarix (TM); influenza vaccine
Influenza is a potentially fatal respiratory infection resulting from several influenza virus strains. It causes annual epidemics of disease for which vaccination is the cornerstone of public health policy. The inadequacies of vaccine supply in the US during the 2004 influenza season revealed the deficiencies of current vaccine development and delivery. One outcome of this was the accelerated approval of an inactivated split-virus influenza vaccine, Fluarix (TM). This paper reviews the immunogenicity and reactogenicity of this vaccine, and makes recommendations for the incorporation of Fluarix (TM) into the public health framework alongside other similar vaccines. Other directions to explore in an effort to secure future vaccine supply are considered.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据